Ras protein's role in spreading cancer

February 18, 2018

WASHINGTON, D.C., Feb. 18, 2018 -- Protein systems, such as Ras, make up the complex signaling pathways that control whether a cell divides or, in some cases, becomes cancerous and metastasizes into other regions of the body. For example, 98 percent of pancreatic cancers show Ras protein mutations.

Ras proteins have long been the focus of cancer research because of their role as "on/off switch" signaling pathways that control cell division and failure to die like normal, healthy cells do. In order for Ras proteins to do their job, they need to bind to a membrane surface. Scientists have tried to pharmaceutically "turn off" the Ras protein, or prevent it from being "turned on", without much success. Now, a team of researchers at the University of Illinois at Urbana-Champaign has been able to study precisely how Ras proteins interact with cell membrane surfaces.

Stephen Sligar and his team have found that the KRas4b form of Ras protein binds more tightly to the cell membrane, but it needs to attach on the correct side.

One side of the KRas4b protein associates with signaling partners; if this side binds to the membrane, then it's not able to interact with its partners, but if the inactive side binds to the membrane, then the active side is available to engage in the downstream signaling process that could enable cancer. Sligar' s team discovered that fatty acids in KRas4b help control which side attaches to the cell membrane.

"The membrane is playing a very critical role in controlling the activity of very complex signaling networks that involve many different protein molecules, Sligar said. "It is now becoming appreciated how much the membrane composition can dictate how these molecules are recruited to the membrane surface, and then how they go about their business."

In the long term, the revitalized interest in the biophysics of KRas4b, and its interaction with the membrane, will hopefully guide the discovery and design of pharmaceuticals for the treatment of cancer.
-end-
167-Plat - "Mechanisms in cancer signaling: The role of the membrane in the recruitment of the oncogene KRas4b" is authored by Stephen G. Sligar, Michael C. Gregory and Mark A. McLean. It will be presented at 10:45 a.m. PST, Sunday, Feb. 18, 2018 in Esplanade, Room 156 of the Moscone Center, South. Abstract: https://plan.core-apps.com/bpsam2018/abstract/ea4b4250733473141a814abfbdb4d6d6

MORE MEETING INFORMATION

ABOUT THE MEETING

Each year, the Biophysical Society Annual Meeting brings together more than 6,000 researchers working in the multidisciplinary fields representing biophysics. With more than 3,600 poster presentations, over 200 exhibits, and more than 20 symposia, the BPS Annual Meeting is the largest meeting of biophysicists in the world. Despite its size, the meeting retains its small-meeting flavor through its subgroup symposia, platform sessions, social activities and committee programs. The 62nd Annual Meeting will be held at the Moscone Center (South) in San Francisco, California.

PRESS REGISTRATION

The Biophysical Society invites professional journalists, freelance science writers and public information officers to attend its Annual Meeting free of charge. For press registration, contact Ellen Weiss at EWeiss@biophysics.org or the Media Line at the American Institute of Physics at media@aip.org or 301-209-3090.

NEWS RELEASES

Embargoed press releases describing in detail some of the breakthroughs to be discussed at the meeting are available on EurekAlert!, Newswise and Alpha Galileo or by contacting the Media Line at the American Institute of Physics at media@aip.org or 301-209-3090.

QUICK LINKS

Main Meeting Page: https://www.biophysics.org/2018meeting/Home/tabid/7117/Default.aspx

Symposia: https://www.biophysics.org/2018meeting/Program/ScientificSessions/Symposia/tabid/7192/Default.aspx

Desktop Planner: http://www.biophysics.org/2018meeting/GeneralInfo/MobileApp/tabid/7473/Default.aspx

ABOUT THE SOCIETY

The Biophysical Society, founded in 1958, is a professional, scientific Society established to encourage development and dissemination of knowledge in biophysics. The Society promotes growth in this expanding field through its annual meeting, monthly journal, and committee and outreach activities. Its 9,000 members are located throughout the U.S. and the world, where they teach and conduct research in colleges, universities, laboratories, government agencies, and industry. For more information on the Society, or the 2018 Annual Meeting, visit http://www.biophysics.org.

Biophysical Society

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.